CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
Chimeric Antigen Receptor (CAR)-T cell therapy has rapidly emerged as a groundbreaking approach in cancer treatment, particularly for hematologic malignancies. However, the application of CAR-T cell therapy in solid tumors remains challenging. This review summarized the development of CAR-T technolo...
Saved in:
Main Authors: | Yaojie Kong, Jingyao Li, Xueyao Zhao, Yanwei Wu, Liang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1519671/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-T Therapy Beyond B-Cell Hematological Malignancies
by: Martina Canichella, et al.
Published: (2025-01-01) -
T-regulatory cells for the treatment of autoimmune diseases
by: Marina S. Fisher, et al.
Published: (2025-02-01) -
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
by: Safwaan H. Khan, et al.
Published: (2025-01-01) -
DETERMINATION OF THE QUALITY INDEX OF CARS
by: Oleksiy BAZHINOV, et al.
Published: (2023-03-01) -
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
by: Qiaolin Huang, et al.
Published: (2025-02-01)